<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>麦肯锡见解与出版物</title><link>https://www.mckinsey.com/</link><description>麦肯锡见解与出版物 RSS 源</description><lastBuildDate>Tue, 01 Sep 2015 08:44:43 GMT</lastBuildDate><generator>rfeed v1.1.1</generator><docs>https://github.com/svpino/rfeed/blob/master/README.md</docs><item><title>将数字化带入 B2B 支付</title><link>https://www.mckinsey.com/industries/financial-services/our-insights/bringing-digital-to-b2b-payments</link><description>连续创业者 René Lacerte 讲述了 BILL 对帮助企业建立联系和进行交易的追求以及他对中小企业的热情。</description><pubDate>Fri, 10 Jan 2025 00:00:00 GMT</pubDate><guid isPermaLink="true">https://www.mckinsey.com/industries/financial-services/our-insights/bringing-digital-to-b2b-payments</guid></item><item><title>扩展生命科学行业的新一代人工智能</title><link>https://www.mckinsey.com/industries/life-sciences/our-insights/scaling-gen-ai-in-the-life-sciences-industry</link><description>Gen AI 试点已显示出希望，但为了让该技术在生命科学行业提供变革性的商业价值，组织需要重新考虑如何扩展它。</description><pubDate>Fri, 10 Jan 2025 00:00:00 GMT</pubDate><guid isPermaLink="true">https://www.mckinsey.com/industries/life-sciences/our-insights/scaling-gen-ai-in-the-life-sciences-industry</guid></item><item><title>Yuhki Yamashita 将“用户喜爱”作为产品主导型增长的动力</title><link>https://www.mckinsey.com/industries/technology-media-and-telecommunications/our-insights/yuhki-yamashita-on-user-love-as-the-fuel-for-product-led-growth</link><description>Figma 首席产品官 Yuhki Yamashita 讨论了如何利用与客户和社区的联系来促进产品主导的增长。</description><pubDate>Fri, 10 Jan 2025 00:00:00 GMT</pubDate><guid isPermaLink="true">https://www.mckinsey.com/industries/technology-media-and-telecommunications/our-insights/yuhki-yamashita-on-user-love-as-the-fuel-for-product-led-growth</guid></item><item><title>迈克尔·弗罗曼谈地缘政治的商业影响</title><link>https://www.mckinsey.com/capabilities/geopolitics/our-insights/michael-froman-on-the-business-implications-of-geopolitics</link><description>美国外交关系委员会主席解释说，当今的企业面临着 80 年来最复杂的国际环境。</description><pubDate>Fri, 10 Jan 2025 00:00:00 GMT</pubDate><guid isPermaLink="true">https://www.mckinsey.com/capabilities/geopolitics/our-insights/michael-froman-on-the-business-implications-of-geopolitics</guid></item><item><title>2025 年及以后美国医疗保健的预期</title><link>https://www.mckinsey.com/industries/healthcare/our-insights/what-to-expect-in-us-healthcare-in-2025-and-beyond</link><description>行业经济正在转向非急性护理服务、医疗保健软件、数据、分析和专业制药领域。</description><pubDate>Fri, 10 Jan 2025 00:00:00 GMT</pubDate><guid isPermaLink="true">https://www.mckinsey.com/industries/healthcare/our-insights/what-to-expect-in-us-healthcare-in-2025-and-beyond</guid></item><item><title>业务建设的隐藏陷阱：生命科学首席执行官指南</title><link>https://www.mckinsey.com/industries/life-sciences/our-insights/the-hidden-traps-of-business-building-a-guide-for-life-science-ceos</link><description>制药、生物技术和医疗技术领域的首席执行官越来越多地建立以患者为中心的业务，但目前进展缓慢。避免五个常见障碍可以帮助领导者建立成功的企业。</description><pubDate>Fri, 10 Jan 2025 00:00:00 GMT</pubDate><guid isPermaLink="true">https://www.mckinsey.com/industries/life-sciences/our-insights/the-hidden-traps-of-business-building-a-guide-for-life-science-ceos</guid></item><item><title>绘制通往患者的路径</title><link>https://www.mckinsey.com/industries/life-sciences/our-insights/charting-the-path-to-patients</link><description>在整个制药研发管道中仔细制定资产战略对于抓住创新机会变得越来越重要。</description><pubDate>Thu, 09 Jan 2025 00:00:00 GMT</pubDate><guid isPermaLink="true">https://www.mckinsey.com/industries/life-sciences/our-insights/charting-the-path-to-patients</guid></item><item><title>外部创新：生物制药交易以提高研发效率</title><link>https://www.mckinsey.com/industries/life-sciences/our-insights/external-innovation-biopharma-dealmaking-to-boost-r-and-d-productivity</link><description>过去十年中表现最好的制药公司依赖于一系列关键的交易行为来推动外部创新生产力的提高。</description><pubDate>Thu, 09 Jan 2025 00:00:00 GMT</pubDate><guid isPermaLink="true">https://www.mckinsey.com/industries/life-sciences/our-insights/external-innovation-biopharma-dealmaking-to-boost-r-and-d-productivity</guid></item><item><title>建立药品研发与供应商合作伙伴关系的共同愿景</title><link>https://www.mckinsey.com/industries/life-sciences/our-insights/building-a-shared-vision-for-pharma-r-and-d-supplier-partnerships</link><description>制药研发领导者及其供应商将透明度视为实现更有效合作和成本效率的关键。</description><pubDate>Thu, 09 Jan 2025 00:00:00 GMT</pubDate><guid isPermaLink="true">https://www.mckinsey.com/industries/life-sciences/our-insights/building-a-shared-vision-for-pharma-r-and-d-supplier-partnerships</guid></item><item><title>利用人工智能解锁临床开发中的最佳运营绩效</title><link>https://www.mckinsey.com/industries/life-sciences/our-insights/unlocking-peak-operational-performance-in-clinical-development-with-artificial-intelligence</link><description>三个灯塔用例作为人工智能提高临床试验速度、效率和质量潜力的蓝图。</description><pubDate>Thu, 09 Jan 2025 00:00:00 GMT</pubDate><guid isPermaLink="true">https://www.mckinsey.com/industries/life-sciences/our-insights/unlocking-peak-operational-performance-in-clinical-development-with-artificial-intelligence</guid></item></channel></rss>